Illumina Expands Presence in Latin America

Sep 30, 2021 Opens Illumina entities in Colombia and México SAN DIEGO, Sept. 30, 2021 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN) announced the creation of Illumina Colombia S.A.S. and Illumina México Productos de Biotecnología marking our commitment to expand genomics in Latin America and increase the level of support for our local customers and partners.  “Colombia... Read more

Avantor Announces Global Distribution Agreement with Oxford Nanopore Technologies for Handheld MinION DNA/RNA Sequencer

Partnership will broaden global access for scientists to benefit from portable DNA/RNA sequencing technology that provides rich data in real time, for life science research applications Oxford Nanopore Technologies MinIONTM and MinIONTM Mk1C DNA/RNA Sequencing Devices RADNOR, Pa. (USA) — Sept. 27, 2021 — Avantor, a leading global provider of mission-critical products and services to customers... Read more

Danaher Schedules Third Quarter 2021 Earnings Conference Call

WASHINGTON, Sept. 21, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the third quarter 2021 on Thursday, October 21, 2021 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the “Investors” section of... Read more

Pacific Biosciences Closes Acquisition of Omniome and Establishes San Diego Presence

Omniome’s high accuracy short-read sequencing platform expected to significantly expand PacBio’s market opportunity Acquisition expected to accelerate the adoption of SMRT Sequencing, PacBio’s leading long-read sequencing platform PacBio also closes $300 million PIPE financing in support of transaction MENLO PARK, Calif., Sept. 20, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB)(“Pacific Biosciences” or “PacBio”),... Read more

Thermo Fisher Scientific Adds Digital PCR to Genetic Analysis Capabilities

Applied Biosystems QuantStudio Absolute Q Digital PCR System*, the first integrated digital PCR solution, is ideal for oncology, cell and gene therapy development and other research applications WALTHAM, Mass., Sept. 20, 2021 /PRNewswire/ — Thermo Fisher Scientific (NYSE: TMO), the world leader in serving science, today launched the Applied Biosystems QuantStudio Absolute Q Digital PCR... Read more

FDA Approves Tissue-Based NGS Companion Diagnostic for Takeda's Targeted Therapy for NSCLC Patients with EGFR Exon20 Insertion Mutations

FDA Approves Tissue-Based NGS Companion Diagnostic for Takeda’s Targeted Therapy for NSCLC Patients with EGFR Exon20 Insertion Mutations Oncomine Dx Target Test now approved as CDx for five targeted NSCLC therapies in the U.S. CARLSBAD, Calif., Sept. 15, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher... Read more

Illumina Accelerator Invests in Seven Genomics Startups for Third Global Cycle

Sep 15, 2021 Diverse investments from Israel, Mexico, Poland, South Africa, United Kingdom and United States SAN DIEGO, Sept. 15, 2021 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN) has selected seven new genomics companies to join the third global funding cycle of Illumina Accelerator. The global company creation engine, focused on partnering with entrepreneurs to build breakthrough genomics startups,... Read more

Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc.

09/14/2021 LAKEWOOD, Colo., Sept. 14, 2021 (GLOBE NEWSWIRE) — Mesa Laboratories, Inc. (NASDAQ:MLAB) (“we”, “us”, “our”, “Mesa” or the “Company”), a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, and medical device industries, announced today that it has entered into a definitive agreement to acquire Agena Bioscience,... Read more

Roche signs definitive share purchase agreement with long-term partner TIB Molbiol to expand PCR-test portfolio in the fight against new infectious diseases

Roche to acquire the TIB Molbiol Group with the expectation to close in fourth quarter of 2021 TIB Molbiol excels in ultra-rapid assay development for emerging infectious disease, strongly demonstrated during the COVID-19 pandemic The acquisition enables Roche to further expand the portfolio of currently over 45 CE-IVD assays and more than 100 research use... Read more